Neil Kumar, BridgeBio

Bridge­Bio team clears a key hur­dle with their proof-of-con­cept da­ta for a rare ge­net­ic dis­ease. And they can thank the NIH for a quick suc­cess

Bridge­Bio’s Cal­ci­lytix team has sev­er­al good rea­sons to of­fer some spe­cial thanks to the NIH to­day.

Mike Collins, an NIH re­searcher and di­vi­sion chief who …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.